Plasma cell leukemia evolving into aggressive extramedullary plasmacytoma by clonal selection

Am J Hematol. 1997 Jul;55(3):156-8. doi: 10.1002/(sici)1096-8652(199707)55:3<156::aid-ajh7>3.0.co;2-r.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Clone Cells
  • Cytarabine / therapeutic use
  • Dexamethasone / therapeutic use
  • Humans
  • Immunoglobulin Class Switching
  • Leukemia, Plasma Cell / drug therapy
  • Leukemia, Plasma Cell / immunology
  • Leukemia, Plasma Cell / pathology*
  • Male
  • Middle Aged
  • Pelvic Neoplasms / drug therapy
  • Pelvic Neoplasms / immunology
  • Pelvic Neoplasms / pathology
  • Plasmacytoma / drug therapy
  • Plasmacytoma / immunology
  • Plasmacytoma / pathology*
  • Plasmacytoma / physiopathology
  • Tomography, X-Ray Computed
  • Vincristine / therapeutic use

Substances

  • Cytarabine
  • Vincristine
  • Dexamethasone

Supplementary concepts

  • VAD regimen